Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.51 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.51 |
| ▸ | RNASEL | Q05823 | 7/20 | 0.50 |
| ▸ | TGM2 | P21980 | 1/20 | 0.49 |
| ▸ | NT5E | P21589 | 1/20 | 0.49 |
| ▸ | FUT5 | Q11128 | 1/20 | 0.48 |
| ▸ | KRAS | P01116 | 2/20 | 0.47 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23679394 | 0.89 | TAS1R3 (0.52) | TAS1R3TAS1R1RNASELTGM2NT5E | |
| SCHEMBL22193777 | 0.80 | RNASEL (0.59) | TAS1R3TAS1R1RNASELTGM2NT5E | |
| SCHEMBL2315645 | 0.79 | NT5E (0.69) | TAS1R3TAS1R1RNASELTGM2NT5E | |
| SCHEMBL31310507 | 0.78 | TAS1R3 (0.67) | TAS1R3TAS1R1RNASELTGM2NT5E | |
| SCHEMBL29324484 | 0.77 | TAS1R3 (0.53) | TAS1R3TAS1R1RNASELTGM2NT5E | |
| SCHEMBL18937290 | 0.77 | RNASEL (0.69) | RNASEL | |
| SCHEMBL19186042 | 0.77 | RNASEL (0.69) | RNASEL | |
| SCHEMBL18320601 | 0.77 | NT5E (0.72) | TAS1R3TAS1R1RNASELTGM2NT5E | |
| SCHEMBL29324598 | 0.77 | POLB (0.49) | TAS1R3TAS1R1TGM2NT5EFUT5 | |
| SCHEMBL25389352 | 0.77 | NT5E (0.68) | TAS1R3TAS1R1TGM2NT5EFUT5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3854799-A1 | CYCLIC DINUCLEOTIDE ANALOGUE, PHARMACEUTICAL COMPOSITION THEREOF, AND APPLICATION | Shanghai de Novo Pharmatech Co., Ltd. (CN) | 2021-07-28 | — | — | EP | disclosed |